India Clears 2 New Vaccines And Merck's Covid Pill

[{"selector":"#anim-100f13ca-229a-4244-afe4-c712462876a4 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(30.664062404002962%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

The two latest vaccines are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.

[{"selector":"#anim-6190f8d3-8367-4017-9bd8-d0818505b780 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-5.73529413607141%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Corbevax is India's first homegrown "RBD protein sub-unit vaccine", It is made by the Hyderabad-based firm Biological-E.

[{"selector":"#anim-c3b17842-97c9-40d8-8e26-3e5cfad21ec8 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

"It's a hat-trick! It's now third vaccine developed in India,". The other two vaccines developed in India are Bharat Biotech's Covaxin and SII Covishield.

[{"selector":"#anim-96e0021e-5995-4c24-82b4-538711a0e3dc [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-4.31038792783804%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The nanoparticle vaccine, Covovax, will be manufactured by the Pune-based SII.

[{"selector":"#anim-8324473d-5d26-40cb-acaa-8b9ff9ae886e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(32.07031240400296%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

The anti-viral drug Molnupiravir will be manufactured in India by 13 companies for restricted use under emergency situation

[{"selector":"#anim-e0e72b2f-8a8e-4a36-8e14-f368702f35e0 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(28.90624987200394%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

[{"selector":"#anim-a05aa1ae-da19-456f-a600-2f3694fa049a [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-33.32499988616884%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Dr Reddy's Laboratories in a consortium with Cipla, Mylan, Torrent, Emcure and Sun Pharma had presented their proposal for approval of Molnupiravir for emergency situation.

In a clinical trial of high-risk people during the early course of illness, Merck's drug was shown to reduce hospitalisations and deaths by around 30 per cent.

[{"selector":"#anim-8f4fd78a-a9c5-48e5-a7b1-66848145d058 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

India will start administering COVID-19 booster shots to healthcare, frontline workers and those above 60 with comorbidities from January 10.

[{"selector":"#anim-117d0e98-6eb2-4c17-bfa2-046aa57e8579 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(24.991861881614117%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]